These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3932310)

  • 1. Molecular mechanism of action of virginiamycin-like antibiotics (synergimycins) on protein synthesis in bacterial cell-free systems.
    Cocito C; Chinali G
    J Antimicrob Chemother; 1985 Jul; 16 Suppl A():35-52. PubMed ID: 3932310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular basis of the inhibitory activities of type A and type B synergimycins and related antibiotics on ribosomes.
    Di Giambattista M; Chinali G; Cocito C
    J Antimicrob Chemother; 1989 Oct; 24(4):485-507. PubMed ID: 2515187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of polypeptide synthesis in cell-free systems by virginiamycin S and erythromycin. Evidence for a common mode of action of type B synergimycins and 14-membered macrolides.
    Chinali G; Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1988 Jan; 949(1):71-8. PubMed ID: 3120788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lasting ribosome alteration produced by virginiamycin M disappears upon removal of certain ribosomal proteins.
    Moureau P; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 Mar; 739(2):164-72. PubMed ID: 6402016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes.
    Di Giambattista M; Engelborghs Y; Nyssen E; Cocito C
    J Biol Chem; 1987 Jun; 262(18):8591-7. PubMed ID: 3110150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic interactions of macrolides and synergimycins on bacterial ribosomes.
    Di Giambattista M; Vannuffel P; Sunazuka T; Jacob T; Omura S; Cocito C
    J Antimicrob Chemother; 1986 Sep; 18(3):307-15. PubMed ID: 3095298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of fluorescence quenching of ribosome-bound virginiamycin S.
    Di Giambattista M; Ide G; Engelborghs Y; Cocito C
    J Biol Chem; 1984 May; 259(10):6334-9. PubMed ID: 6427212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribosome protection by tRNA derivatives against inactivation by virginiamycin M: evidence for two types of interaction of tRNA with the donor site of peptidyl transferase.
    Chinali G; Di Giambattista M; Cocito C
    Biochemistry; 1987 Mar; 26(6):1592-7. PubMed ID: 3109469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of virginiamycin M on the stability of different ribosomal complexes to ultracentrifugation.
    Chinali G; Vanlinden F; Cocito C
    Biochim Biophys Acta; 1988 May; 950(1):67-74. PubMed ID: 3129013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence stopped flow analysis of the interaction of virginiamycin components and erythromycin with bacterial ribosomes.
    Moureau P; Engelborghs Y; Di Giambattista M; Cocito C
    J Biol Chem; 1983 Dec; 258(23):14233-8. PubMed ID: 6417137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The action of virginiamycin M on the acceptor, donor, and catalytic sites of peptidyltransferase.
    Chinali G; Moureau P; Cocito CG
    J Biol Chem; 1984 Aug; 259(15):9563-8. PubMed ID: 6430902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the reversible binding of virginiamycin M to ribosome and particle functions after removal of the antibiotic.
    Nyssen E; Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1989 Sep; 1009(1):39-46. PubMed ID: 2506929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of virginiamycin S binding site on bacterial ribosome by fluorescence energy transfer.
    Di Giambattista M; Thielen AP; Maassen JA; Möller W; Cocito C
    Biochemistry; 1986 Jun; 25(12):3540-7. PubMed ID: 3087416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vitro and in vivo inactivation of ribosomes by virginiamycin M does not entail an alteration of 5, 16 and 23 S ribosomal RNA.
    Cocito C; Vanlinden F; Branlant C
    Biochim Biophys Acta; 1983 Mar; 739(2):158-63. PubMed ID: 6402015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Action of ions and pH on the binding of virginiamycin S to ribosomes.
    Di Giambattista M; Cocito C
    Biochim Biophys Acta; 1983 May; 757(1):92-100. PubMed ID: 6404307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lasting damage to bacterial ribosomes by reversibly bound virginiamycin M.
    Parfait R; Cocito C
    Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5492-6. PubMed ID: 6776538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of streptogramins and macrolides.
    Vannuffel P; Cocito C
    Drugs; 1996; 51 Suppl 1():20-30. PubMed ID: 8724813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical probing of a virginiamycin M-promoted conformational change of the peptidyl-transferase domain.
    Vannuffel P; Di Giambattista M; Cocito C
    Nucleic Acids Res; 1994 Oct; 22(21):4449-53. PubMed ID: 7971275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A spectrofluorimetric study of the interaction between virginiamycin S and bacterial ribosomes.
    Parfait R; de Béthune MP; Cocito C
    Mol Gen Genet; 1978 Oct; 166(1):45-51. PubMed ID: 105239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity labeling of the virginiamycin S binding site on bacterial ribosome.
    Di Giambattista M; Nyssen E; Pecher A; Cocito C
    Biochemistry; 1990 Oct; 29(39):9203-11. PubMed ID: 2125475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.